TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35550262

Group type: EXPERIMENTAL
Intervention: Doxycycline (100 mg twice per day for 7 days)
Number of subjects: 460

Group type: COMPARATOR
Intervention: Azithromycin (single 1-g dose)
Number of subjects: 460

Group type: EXPERIMENTAL
Intervention: Doxycycline
Number of subjects: 460

Group type: COMPARATOR
Intervention: Azithromycin
Number of subjects: 460
Study: 33435831

Group type: COMPARATOR
Intervention: CIT (Conventional Constraint-Induced Therapy)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: CIT-Wii (Wii-augmented Constraint-Induced Therapy)
Number of subjects: 18
Study: 33445196

Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin (PRF) applied around the esophageal stoma during total laryngectomy
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no PRF application)
Number of subjects: 20
Study: 33319645

Group type: EXPERIMENTAL
Intervention: Arabinoxylan-oligosaccharides (AXOS) 10.4 g/d
Number of subjects: 29

Group type: COMPARATOR
Intervention: Polyunsaturated fatty acids (PUFA) 3.6 g/d
Number of subjects: 29
Study: 32186048

Group type: EXPERIMENTAL
Intervention: Acupuncture plus medication (amlodipine 5 mg once daily)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Medication only (amlodipine 5 mg once daily)
Number of subjects: 80
Study: 35997173

Group type: EXPERIMENTAL
Intervention: 0.1% A. annua extract (AAE)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 90
Study: 33975741

Group type: EXPERIMENTAL
Intervention: Flash Glucose Monitoring (FGM)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Self‐monitoring of blood glucose (SMBG)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups (FG and CG)
Number of subjects: 40
Study: 32739548

Group type: EXPERIMENTAL
Intervention: ERAS protocol with respiratory prehabilitation (incentive spirometry)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Conventional perioperative care
Number of subjects: 58
Study: 35627640

Group type: EXPERIMENTAL
Intervention: Chest resistance and expansion exercises (12-week program, 3 sessions per week)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Usual chest physiotherapy program (control group)
Number of subjects: 32
Study: 34246825

Group type: EXPERIMENTAL
Intervention: CollaStat
Number of subjects: 78

Group type: COMPARATOR
Intervention: Floseal
Number of subjects: 78
Study: 33567193

Group type: EXPERIMENTAL
Intervention: Vaccine
Number of subjects: 548

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 548
Study: 32593717

Group type: EXPERIMENTAL
Intervention: Aging Back Clinics (ABCs)
Number of subjects: 330

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 330
Study: 32964434

Group type: EXPERIMENTAL
Intervention: Non-esterified fatty acids (NEFAs)
Number of subjects: 4710
Study: 35612859

Group type: EXPERIMENTAL
Intervention: Antibiotics (self-selection cohort)
Number of subjects: 1604

Group type: COMPARATOR
Intervention: Antibiotics (randomized cohort)
Number of subjects: 1604

Group type: EXPERIMENTAL
Intervention: Appendectomy (self-selection cohort)
Number of subjects: 1604

Group type: COMPARATOR
Intervention: Appendectomy (randomized cohort)
Number of subjects: 1604
Study: 33682286

Group type: EXPERIMENTAL
Intervention: Radiomics models based on automatic segmentation on ADC maps
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Radiomics models based on manual segmentation on ADC maps
Number of subjects: 176

Group type: COMPARATOR
Intervention: Biopsy
Number of subjects: 176

Group type: COMPARATOR
Intervention: PI-RADS assessment
Number of subjects: 176
Study: 32698903

Group type: EXPERIMENTAL
Intervention: Single beta‐conglycinin intake
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Beta‐conglycinin intake (2 weeks)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo group (control)
Number of subjects: 22
Study: 34581266

Group type: EXPERIMENTAL
Intervention: Meaning‐Centered Psychotherapy and Essential Care (MCP‐EC)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Usual psychological supportive intervention
Number of subjects: 30
Study: 33597488

Group type: EXPERIMENTAL
Intervention: Households with malaria treatment and prevention measures
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: High-income households
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Low-income households
Number of subjects: 360
Study: 35394710

Group type: EXPERIMENTAL
Intervention: E‐CTG
Number of subjects: 42

Group type: COMPARATOR
Intervention: SCAF
Number of subjects: 42
Study: 34517878

Group type: EXPERIMENTAL
Intervention: Tai Chi exercise
Number of subjects: 226

Group type: COMPARATOR
Intervention: Walking exercises (Control)
Number of subjects: 226
Study: 35585427

Group type: EXPERIMENTAL
Intervention: 0.25% reproxalap
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 0.5% reproxalap
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 0
Study: 36059099

Group type: EXPERIMENTAL
Intervention: Active cTBS
Number of subjects: 32

Group type: COMPARATOR
Intervention: Sham cTBS
Number of subjects: 32
Study: 34520506

Group type: EXPERIMENTAL
Intervention: Rocuronium (group R)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Normal saline (group C)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Sugammadex (group B)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Normal saline (group D)
Number of subjects: 40
Study: 36427515

Group type: EXPERIMENTAL
Intervention: eMBCT (online mindfulness-based cognitive therapy) for 12 weeks
Number of subjects: 99

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: eMBCT
Number of subjects: 99
Study: 33168966

Group type: EXPERIMENTAL
Intervention: Poly(adenosine diphosphate [ADP]‐ribose) polymerase inhibitors (PARPi) for patients with homologous recombination repair (HRR) gene mutations
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Novel androgen receptor (AR) degraders
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Radioligand therapy (RLT) with Lu‐PSMA‐617 (Lu‐PSMA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Immune‐directed therapies (including PD-1 inhibition, BiTE technology, CAR T-cell therapy)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Therapies targeting the PI3K‐Akt‐mTOR pathway and EZH2
Number of subjects: 0
Study: 32469838

Group type: EXPERIMENTAL
Intervention: Active stimulation (2 mA, 20 min, anodal left‐ cathodal right DLPFC)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 32
Study: 36099170

Group type: EXPERIMENTAL
Intervention: Low-load resistance training with blood flow restriction (LLRT-BFR)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Low-load resistance training with sham-BFR
Number of subjects: 46
Study: 33511544

Group type: EXPERIMENTAL
Intervention: Relaparotomy
Number of subjects: 181

Group type: COMPARATOR
Intervention: Primary laparotomy
Number of subjects: 181
Study: 32358398

Group type: EXPERIMENTAL
Intervention: Eye-acupuncture combined with routine treatment
Number of subjects: 360

Group type: COMPARATOR
Intervention: Routine treatment
Number of subjects: 360
Study: 35484580

Group type: EXPERIMENTAL
Intervention: Semaglutide
Number of subjects: 0

Group type: COMPARATOR
Intervention: GLP-1RA
Number of subjects: 0
Study: 34704393

Group type: EXPERIMENTAL
Intervention: Natalizumab
Number of subjects: 0
Study: 32507863

Group type: EXPERIMENTAL
Intervention: SD plus systemic MOX (400 mg QD for 7 days)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: SD plus systemic AMOX+ME (500 mg TID each for 7 days)
Number of subjects: 36

Group type: COMPARATOR
Intervention: SD plus placebo
Number of subjects: 36
Study: 35237339

Group type: EXPERIMENTAL
Intervention: MRI+MRM
Number of subjects: 96

Group type: COMPARATOR
Intervention: MRI
Number of subjects: 96
Study: 33115760

Group type: EXPERIMENTAL
Intervention: upadacitinib 15 mg
Number of subjects: 3834

Group type: EXPERIMENTAL
Intervention: upadacitinib 30 mg
Number of subjects: 3834

Group type: COMPARATOR
Intervention: adalimumab
Number of subjects: 3834

Group type: COMPARATOR
Intervention: methotrexate
Number of subjects: 3834

Group type: EXPERIMENTAL
Intervention: upadacitinib 15 mg and 30 mg
Number of subjects: 3834

Group type: COMPARATOR
Intervention: methotrexate and adalimumab
Number of subjects: 3834
Study: 32410265

Group type: EXPERIMENTAL
Intervention: Pentoxifylline
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Theophylline
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 15
Study: 35078009

Group type: EXPERIMENTAL
Intervention: Minimally invasive surgical (MIS) radical hysterectomy (RH)
Number of subjects: 5575
Study: 34508654

Group type: EXPERIMENTAL
Intervention: Subcutaneous epcoritamab (0.0128-60 mg)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Subcutaneous epcoritamab (48 mg)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Subcutaneous epcoritamab (0.76-48 mg)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Subcutaneous epcoritamab
Number of subjects: 73
Study: 32407973

Group type: EXPERIMENTAL
Intervention: Early treadmill exercise after ICH (ICH + ET)
Number of subjects: 4

Group type: COMPARATOR
Intervention: No training after ICH (ICH)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Late treadmill exercise after ICH (ICH + LT)
Number of subjects: 4
Study: 35968375

Group type: EXPERIMENTAL
Intervention: Active ISF-NF training
Number of subjects: 22

Group type: COMPARATOR
Intervention: Sham ISF-NF training
Number of subjects: 22
Study: 35170383

Group type: EXPERIMENTAL
Intervention: Preoperative theatre visit with an informative session regarding the surgery
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group (no preoperative theatre visit)
Number of subjects: 64
Study: 33950550

Group type: EXPERIMENTAL
Intervention: Cannabis use disorder (CUD)
Number of subjects: 161405
Study: 33353965

Group type: EXPERIMENTAL
Intervention: Type 1 diabetes (T1D)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 23
Study: 35292232

Group type: EXPERIMENTAL
Intervention: Geriatric Evaluation and Management‐Survivorship (GEMS) intervention
Number of subjects: 780
Study: 32224723

Group type: EXPERIMENTAL
Intervention: Pediatric anesthesiology fellowship training
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Anesthesiology residency training
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Gender diversity in pediatric anesthesiology fellowship programs
Number of subjects: 202
Study: 35647963

Group type: EXPERIMENTAL
Intervention: Evolve Pure™ Eyewipes twice a day along with standard therapy (antibiotic and lubricants)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Warm compresses along with standard therapy
Number of subjects: 50
Study: 34371004

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sodium thiosulfate (STS)
Number of subjects: 0
Study: 33143987

Group type: EXPERIMENTAL
Intervention: Computer-facilitated Screening and Brief Intervention (cSBI) system
Number of subjects: 54

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 54
Study: 32902075

Group type: EXPERIMENTAL
Intervention: Extraction sockets filled with bovine bone mineral and membrane with EMD (test group 1)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Extraction sockets filled with bovine bone mineral and membrane without EMD (test group 2)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Spontaneous healing (control group)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Test groups 1 and 2 (with and without EMD)
Number of subjects: 28
Study: 35925809

Group type: EXPERIMENTAL
Intervention: Telemedicine integrated into opioid treatment programs (OTPs)
Number of subjects: 344

Group type: COMPARATOR
Intervention: Offsite referral
Number of subjects: 344
Study: 35841489

Group type: EXPERIMENTAL
Intervention: RTCP + UC
Number of subjects: 108

Group type: COMPARATOR
Intervention: UC
Number of subjects: 108
Study: 33560891

Group type: EXPERIMENTAL
Intervention: MT-1207 (5-40 mg)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: MT-1207 (40 mg) with food
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: MT-1207 (5-20 mg)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: MT-1207
Number of subjects: 56
Study: 34266340

Group type: EXPERIMENTAL
Intervention: Specialized ruler for preoperative marking (Group 2)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Classic technique for preoperative marking (Group 1)
Number of subjects: 42
Study: 33982896

Group type: EXPERIMENTAL
Intervention: Diclofenac-Hyaluronate Conjugate
Number of subjects: 1

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1
Study: 36099269

Group type: EXPERIMENTAL
Intervention: Paracetamol (APAP) use during pregnancy
Number of subjects: 232
Study: 34902299

Group type: EXPERIMENTAL
Intervention: Frail White male SP
Number of subjects: 855

Group type: EXPERIMENTAL
Intervention: Frail Black male SP
Number of subjects: 855

Group type: COMPARATOR
Intervention: Vigorous male SP
Number of subjects: 855

Group type: COMPARATOR
Intervention: Ratings by male workers
Number of subjects: 855
Study: 32617960

Group type: EXPERIMENTAL
Intervention: DAV132 (10 dose regimens)
Number of subjects: 143

Group type: COMPARATOR
Intervention: Moxifloxacin only
Number of subjects: 143

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 143
Study: 33421045

Group type: EXPERIMENTAL
Intervention: Black mulberry syrup gargling (5 ml, 3 times a day for 15 days)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no intervention specified)
Number of subjects: 40
Study: 34459400

Group type: EXPERIMENTAL
Intervention: Apabetalone
Number of subjects: 464

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 464
Study: 32619792

Group type: EXPERIMENTAL
Intervention: Healthy New Nordic Diet (NND)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Average Danish Diet (ADD)
Number of subjects: 142
Study: 34748169

Group type: EXPERIMENTAL
Intervention: Routine calcium and vitamin D supplementation (group B)
Number of subjects: 203

Group type: COMPARATOR
Intervention: Calcium and vitamin D supplementation exclusively to symptomatic patients (group A)
Number of subjects: 203
Study: 32878424

Group type: EXPERIMENTAL
Intervention: Weight vest technical‐tactical training (WTG)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Weight vest plyometric training (WPG)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: All training groups (WPG, WTG, CG)
Number of subjects: 15
Study: 33671235

Group type: EXPERIMENTAL
Intervention: Blue whiting-derived protein hydrolysate (BWPH)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Whey protein isolate (WPI)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Non-essential amino acid (NEAA) control
Number of subjects: 7
Study: 33262331

Group type: EXPERIMENTAL
Intervention: EFV-based therapy
Number of subjects: 1053

Group type: EXPERIMENTAL
Intervention: DTG-based therapy
Number of subjects: 1053

Group type: EXPERIMENTAL
Intervention: Total cohort
Number of subjects: 1053
Study: 35939436

Group type: COMPARATOR
Intervention: Two-finger technique (2FT)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Two-thumb encircling technique (2TT)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Cross-thumb technique (CTT)
Number of subjects: 3
Study: 35331537

Group type: EXPERIMENTAL
Intervention: Individualised nutrition therapy including 5 home visits and 3 phone calls, energy- and protein-rich foods, and oral nutrition supplements for six months.
Number of subjects: 106

Group type: COMPARATOR
Intervention: Standard care (control group).
Number of subjects: 106
Study: 32078512

Group type: EXPERIMENTAL
Intervention: Tailored occupation-based intervention administered for 7 weeks in individual 1-hour sessions, focusing on routine establishment, organization, time management, stress management, and sensory regulation.
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 23
Study: 35854212

Group type: EXPERIMENTAL
Intervention: ddPCR assay
Number of subjects: 2292

Group type: COMPARATOR
Intervention: Standard practice (control group)
Number of subjects: 2292
Study: 34086002

Group type: EXPERIMENTAL
Intervention: Liposomal bupivacaine
Number of subjects: 102

Group type: COMPARATOR
Intervention: Bupivacaine with epinephrine and dexamethasone
Number of subjects: 102
Study: 32885808

Group type: EXPERIMENTAL
Intervention: 2 mg/day pitavastatin for 12 weeks
Number of subjects: 34

Group type: COMPARATOR
Intervention: 10 mg/day atorvastatin for 12 weeks
Number of subjects: 34
Study: 35090047

Group type: EXPERIMENTAL
Intervention: Atezolizumab
Number of subjects: 1327

Group type: COMPARATOR
Intervention: Docetaxel
Number of subjects: 1327

Group type: EXPERIMENTAL
Intervention: On-treatment LDH (elevated at weeks 6, 12, 18, and 24)
Number of subjects: 1327

Group type: EXPERIMENTAL
Intervention: On-treatment LDH (elevated at 6 weeks)
Number of subjects: 1327

Group type: EXPERIMENTAL
Intervention: On-treatment LDH (elevated at 12 weeks)
Number of subjects: 1327
Study: 33577375

Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) therapy; 8 sessions applied during cardiac rehabilitation (CR).
Number of subjects: 34

Group type: COMPARATOR
Intervention: Schultz' Autogenic Training; 8 sessions applied during cardiac rehabilitation (CR).
Number of subjects: 34
Study: 32386511

Group type: EXPERIMENTAL
Intervention: Nurses using CDSS
Number of subjects: 1294

Group type: EXPERIMENTAL
Intervention: Physicians with different medical specialties
Number of subjects: 1294

Group type: COMPARATOR
Intervention: GPs
Number of subjects: 1294
Study: 33933012

Group type: EXPERIMENTAL
Intervention: Oral prednisolone treatment starting with 60 mg daily tapered over 8 weeks
Number of subjects: 110

Group type: COMPARATOR
Intervention: No prednisolone treatment (control group)
Number of subjects: 110
Study: 32084431

Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) injection
Number of subjects: 18

Group type: COMPARATOR
Intervention: Acipimox (anti-lipolytic agent)
Number of subjects: 18

Group type: COMPARATOR
Intervention: GH-receptor antagonist
Number of subjects: 18
Study: 33144346

Group type: EXPERIMENTAL
Intervention: Video-tailored intervention
Number of subjects: 501

Group type: EXPERIMENTAL
Intervention: Text-tailored intervention
Number of subjects: 501

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 501
Study: 32379635

Group type: EXPERIMENTAL
Intervention: Lemon inhalation aromatherapy
Number of subjects: 100

Group type: COMPARATOR
Intervention: Paraffin (Control)
Number of subjects: 100
Study: 35553043

Group type: EXPERIMENTAL
Intervention: NAC-GED 5%
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: NAC-GED 2%
Number of subjects: 450

Group type: COMPARATOR
Intervention: Vehicle (placebo)
Number of subjects: 450
Study: 34324430

Group type: EXPERIMENTAL
Intervention: Zoledronic acid (ZOL)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 56
Study: 33175624

Group type: EXPERIMENTAL
Intervention: Glycologic infection detection kit
Number of subjects: 136
Study: 35313227

Group type: EXPERIMENTAL
Intervention: Sodium valproate (800 mg IV in 150 mL normal saline over 5 minutes)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Ibuprofen (800 mg IV in 150 mL normal saline over 5 minutes)
Number of subjects: 99
Study: 33837491

Group type: EXPERIMENTAL
Intervention: Patient-wearable sensor
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 1000
Study: 35500536

Group type: EXPERIMENTAL
Intervention: Anle138b (dose range 50 mg to 300 mg per day)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Anle138b (multiple doses of 200 mg)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Anle138b (150 mg per day)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo (excipient only)
Number of subjects: 68
Study: 33738583

Group type: EXPERIMENTAL
Intervention: Bridged one-anastomosis gastric bypass (BOAGB)
Number of subjects: 44
Study: 32814582

Group type: EXPERIMENTAL
Intervention: Long-chain arabinoxylan (25 g/day for females; 35 g/day for males)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Microcrystalline cellulose (non-fermentable control)
Number of subjects: 31
Study: 35323040

Group type: EXPERIMENTAL
Intervention: 5 days of beta-lactam treatment
Number of subjects: 171

Group type: COMPARATOR
Intervention: 10 days of beta-lactam treatment
Number of subjects: 171
Study: 32722370

Group type: EXPERIMENTAL
Intervention: Anaerostipes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Desulfovibrio spp.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Acidaminococcus, Bacteroides, Bifidobacterium, Faecalibacterium, Lactobacillus, Megamonas
Number of subjects: 0
Study: 35176141

Group type: EXPERIMENTAL
Intervention: Detection of CHIP in SLE patients
Number of subjects: 573

Group type: EXPERIMENTAL
Intervention: Detection of CHIP at inclusion
Number of subjects: 573
Study: 32077731

Group type: EXPERIMENTAL
Intervention: Parental emotion socialization (PES) intervention
Number of subjects: 255

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 255
Study: 35534364

Group type: EXPERIMENTAL
Intervention: Condoliase
Number of subjects: 356

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 356
Study: 34308815

Group type: EXPERIMENTAL
Intervention: Gelfoam packing
Number of subjects: 80

Group type: COMPARATOR
Intervention: No gelfoam packing
Number of subjects: 80
Study: 32952009

Group type: EXPERIMENTAL
Intervention: F + V (Fruits and Vegetables)
Number of subjects: 108

Group type: COMPARATOR
Intervention: NaHCO3 (HCO3‐)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: F + V
Number of subjects: 108

Group type: COMPARATOR
Intervention: F + V and NaHCO3 (HCO3‐)
Number of subjects: 108
Study: 34990854

Group type: EXPERIMENTAL
Intervention: Onsite buprenorphine treatment initiation
Number of subjects: 250

Group type: COMPARATOR
Intervention: Enhanced referral
Number of subjects: 250
Study: 35380643

Group type: EXPERIMENTAL
Intervention: Empowerment-based self-care education program
Number of subjects: 236

Group type: COMPARATOR
Intervention: Didactic education program
Number of subjects: 236
Study: 34229554

Group type: EXPERIMENTAL
Intervention: Ramucirumab plus FOLFIRI
Number of subjects: 1072

Group type: COMPARATOR
Intervention: Placebo plus FOLFIRI
Number of subjects: 1072

Group type: COMPARATOR
Intervention: Ramucirumab vs Placebo
Number of subjects: 1072
Study: 33029118

Group type: EXPERIMENTAL
Intervention: High cortisol levels
Number of subjects: 229

Group type: COMPARATOR
Intervention: Low cortisol levels
Number of subjects: 229
Study: 35240966

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (HCQ) 200 mg 3 times a day (600mg daily) plus conventional treatment
Number of subjects: 260